Healthcare Stock Jumps 8% After Shares Worth ₹128 Cr Change Hands via Block Deal

Synopsis: The stock rose around 8 percent after a Rs 128 crore block deal, with management also increasing its FY27 revenue target to over Rs 660 crore.

The shares of this company, which is an Indian manufacturer and global exporter of male and female condoms, personal lubricants, and in-vitro diagnostic (IVD) kits, gained focus after a block deal.

With a market capitalization of Rs 28,675 crore, Cupid Ltd’s share on Monday made a day high of Rs 214 per share, up by 7.6 percent from its previous day’s close of Rs 198.90 per share. The company’s share has a return of 890 percent in the last 1 year.

What happened

Cupid Ltd came into focus after a Rs 128 crore block deal took place on Monday. Exchange data showed that around 60.8 lakh shares, representing nearly 2.3 percent of the company’s outstanding equity, changed hands in the transaction.

A block deal of this size usually grabs investors’ attention as it involves a large number of shares changing hands in a single transaction. While the buyer and seller are yet to be disclosed, such deals are often closely watched as they can signal institutional activity or a change in major shareholding patterns.

As of Q4 FY26, Cupid Ltd’s promoter holding increased to 46.03 percent from 42.51 percent a year ago. During the same period, FII holding declined to 1.01 percent from 1.63 percent, while DII holding rose slightly to 0.17 percent from 0.11 percent. The public shareholding stood at 52.79 percent, down from 55.75 percent in Q4 FY25.

Recent developments: Cupid Ltd expects to report Q1 FY27 revenue of more than Rs 150 crore, which would mark one of the strongest quarterly performances in the company’s history. Encouraged by the strong start to the year and improving demand across domestic and international markets, the management has raised its FY27 revenue guidance by at least 10 percent, increasing it from Rs 600 crore to over Rs 660 crore.

About the Company 

Cupid Limited, a leading manufacturer & supplier of quality Male condoms, Female  Condoms, water-based lubricant jelly & IVD kits, was incorporated in 1993. Its modern facility has a current capacity of over 480 million pieces of male condoms, 52 million pieces of female condoms & 210 million sachets of Lubricant Jelly per annum. Its manufacturing facility is located at Sinnar near Nashik, about 200 Km. East of Mumbai.

Financial Highlights: Revenue from operations of Rs 132 crore, up around 116 percent YoY from Q4 FY25 revenue of Rs 61 crore. The operating margin improved to 38 percent in Q4 FY26 from 30 percent in Q4 FY25. Net profit increased 200 percent YoY to Rs 36 crore in Q4 FY26, compared to Rs 12 crore in Q4 FY25, while earnings per share rose 200 percent to Rs 0.27 in Q4 FY26 from Rs 0.09 per share in Q4 FY25.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Healthcare Stock Jumps 8% After Shares Worth ₹128 Cr Change Hands via Block Deal appeared first on Trade Brains.